MELISSA SENN: Open Payments
NPI 1033735204 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,226 in 201 payments from 20 companies in 2025. Trend: 2023 $952 · 2024 $2,632 · 2025 $4,226
Food & beverage: $3,962Education: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $662 |
| UCB, Inc. | 17 | $605 |
| Regeneron Healthcare Solutions, Inc. | 25 | $566 |
| Incyte Corporation | 12 | $354 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $269 |
| GENZYME CORPORATION | 14 | $257 |
| Galderma Laboratories, L.P. | 23 | $255 |
| Janssen Biotech, Inc. | 11 | $222 |
| Novartis Pharmaceuticals Corporation | 14 | $213 |
| Organon LLC | 6 | $136 |
Products named: DUPIXENT, Bimzelx, OPZELURA, RINVOQ, SKYRIZI, NEMLUVIO, TREMFYA, COSENTYX.
Industry payments across SC — which companies pay providers there.
